Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis
- PMID: 2097705
Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis
Abstract
The animal model of endocarditis provides a reliable and reproducible model of acute infection and appears appropriate for studying the parameters involved in the in vivo efficacy of antibiotic therapy. The following points are discussed: (i) beta-lactam antibiotics exhibit a time-dependent bactericidal effect which explains the importance of t1/2 beta in the determination of dosing intervals and the need for large unitary doses for increasing efficacy through extending the period of serum levels greater than MIC (ii). The impact of unitary doses and dosing intervals of aminoglycosides on their in vivo synergism with beta-lactams has been investigated in Escherichia coli and streptococcal infections. Once- daily dosing of netilmicin appears very synergistic with ceftriaxone on E. coli, and the aminoglycoside has a significant dose effect. Conversely, divided doses are necessary to exhibit full synergistic effect with penicillin G on E. faecalis. Different patterns of in vivo synergism can therefore be individualized (iii). The rapid bactericidal effect of quinolones and their in vivo post-antibiotic effect allowing large intervals between doses have been investigated with ciprofloxacin (iv). The importance of t1/2 beta on the in vivo effect of glycopeptides is illustrated by data comparing teicoplanin and vancomycin. It is concluded that in vitro killing rate within 3 h is the major factor interfering with the dose interval, followed by t1/2 beta which is of major importance for those drugs whose bactericidal effect is time-dependent. These parameters appear to have a similar importance in experimental endocarditis to that in other experimental models. However, infected vegetations represent a particular focus of infection incorporating heterogeneity of antibiotic distribution, high density of bacteria and reduced metabolic activity of microorganisms. These factors may explain the lack of in vivo postantibiotic effect observed with some antibiotics, correspondingly shorter dosage intervals in endocarditis than in other types of infections and a need for high unitary doses.
Similar articles
-
The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.Dan Med Bull. 2000 Nov;47(5):313-27. Dan Med Bull. 2000. PMID: 11155659 Review.
-
Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.Dan Med Bull. 1988 Oct;35(5):422-37. Dan Med Bull. 1988. PMID: 3066588 Review.
-
Aminoglycoside resistant enterococcal endocarditis.Infect Dis Clin North Am. 1993 Mar;7(1):117-33. Infect Dis Clin North Am. 1993. PMID: 8463648 Review.
-
Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.Scand J Infect Dis Suppl. 1990;74:147-54. Scand J Infect Dis Suppl. 1990. PMID: 2097702 Review.
-
[Contribution of the experimental model of bacterial endocarditis].Bull Acad Natl Med. 1995 Apr;179(4):767-74; discussion 775-6. Bull Acad Natl Med. 1995. PMID: 7648311 Review. French.
Cited by
-
Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 2001 Aug;45(8):2304-8. doi: 10.1128/AAC.45.8.2304-2308.2001. Antimicrob Agents Chemother. 2001. PMID: 11451689 Free PMC article.
-
Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.Antimicrob Agents Chemother. 1994 Sep;38(9):2034-40. doi: 10.1128/AAC.38.9.2034. Antimicrob Agents Chemother. 1994. PMID: 7811015 Free PMC article.
-
Relevance of animal models for clinical treatment.Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S55-7. doi: 10.1007/BF02389879. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8477764 Review.
-
Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.Antimicrob Agents Chemother. 1992 Oct;36(10):2069-74. doi: 10.1128/AAC.36.10.2069. Antimicrob Agents Chemother. 1992. PMID: 1444286 Free PMC article. Review. No abstract available.
-
In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.Antimicrob Agents Chemother. 2002 Dec;46(12):3706-11. doi: 10.1128/AAC.46.12.3706-3711.2002. Antimicrob Agents Chemother. 2002. PMID: 12435665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical